Business · 02/03/1994Updated: 10/15/2026 · 1 min read
Riker Laboratories, Inc., et al.; Withdrawal of Approval of 91 New Drug Applications
Summary
The Food and Drug Administration (FDA) is withdrawing approval of 91 new drug applications (NDA's) after the holders notified the agency in writing that the drug products were no longer being marketed under the NDA's.
Original source language: Federal Register — Health and Human ServicesOpen original release →